CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 3 Months Ended |
Mar. 31, 2021 | Mar. 31, 2020 |
Operating activities: | | |
Net income | $ 52,371 | $ 59,781 |
Adjustments to reconcile net income to net cash provided by operating activities: | | |
Depreciation and amortization | 83,420 | 83,017 |
Accretion of debt premium and discount, net | (725) | (79) |
Deferred financing cost amortization | 1,881 | 1,763 |
Accretion of above- and below-market leases, net | (2,930) | (4,229) |
Tenant inducement amortization and other | 2,071 | 897 |
Impairment of real estate assets | 1,467 | 4,598 |
Gain on sale of real estate assets | (5,764) | (8,905) |
Equity based compensation | 2,592 | 2,652 |
Loss on extinguishment of debt, net | 1,197 | 5 |
Changes in operating assets and liabilities: | | |
Receivables, net | 7,084 | (1,407) |
Deferred charges and prepaid expenses | (3,815) | (6,995) |
Other assets | (58) | (200) |
Accounts payable, accrued expenses and other liabilities | (28,278) | (35,828) |
Net cash provided by operating activities | 110,513 | 95,070 |
Investing activities: | | |
Improvements to and investments in real estate assets | (62,844) | (86,696) |
Acquisitions of real estate assets | (3,779) | (2,020) |
Proceeds from sales of real estate assets | 31,793 | 41,411 |
Purchase of marketable securities | (3,894) | (3,328) |
Proceeds from sale of marketable securities | 4,599 | 4,019 |
Net cash used in investing activities | (34,125) | (46,614) |
Financing activities: | | |
Repayment of secured debt obligations | 0 | (7,000) |
Repayment of borrowings under unsecured revolving credit facility | 0 | (7,500) |
Proceeds from borrowings under unsecured revolving credit facility | 0 | 646,000 |
Proceeds from unsecured notes | 349,360 | 0 |
Repayment of borrowings under unsecured term loans | (350,000) | 0 |
Deferred financing and debt extinguishment costs | (3,088) | (404) |
Distributions to common stockholders | (64,950) | (85,572) |
Repurchases of common shares | 0 | (25,007) |
Repurchases of common shares in conjunction with equity award plans | (5,113) | (3,405) |
Net cash provided by (used in) financing activities | (73,791) | 517,112 |
Net change in cash, cash equivalents and restricted cash | 2,597 | 565,568 |
Cash, cash equivalents and restricted cash at beginning of period | 370,087 | 21,523 |
Cash, cash equivalents and restricted cash at end of period | 372,684 | 587,091 |
Reconciliation to consolidated balance sheets: | | |
Cash and cash equivalents | 371,402 | 584,830 |
Cash, cash equivalents and restricted cash at end of period | 372,684 | 587,091 |
Supplemental disclosure of cash flow information: | | |
Cash paid for interest, net of amount capitalized of $931 and $1,063 | 54,388 | 47,023 |
Brixmor Operating Partnership LP | | |
Operating activities: | | |
Net income | 52,371 | 59,781 |
Adjustments to reconcile net income to net cash provided by operating activities: | | |
Depreciation and amortization | 83,420 | 83,017 |
Accretion of debt premium and discount, net | (725) | (79) |
Deferred financing cost amortization | 1,881 | 1,763 |
Accretion of above- and below-market leases, net | (2,930) | (4,229) |
Tenant inducement amortization and other | 2,071 | 897 |
Impairment of real estate assets | 1,467 | 4,598 |
Gain on sale of real estate assets | (5,764) | (8,905) |
Equity based compensation | 2,592 | 2,652 |
Loss on extinguishment of debt, net | 1,197 | 5 |
Changes in operating assets and liabilities: | | |
Receivables, net | 7,084 | (1,407) |
Deferred charges and prepaid expenses | (3,815) | (6,995) |
Other assets | (58) | (200) |
Accounts payable, accrued expenses and other liabilities | (28,278) | (35,828) |
Net cash provided by operating activities | 110,513 | 95,070 |
Investing activities: | | |
Improvements to and investments in real estate assets | (62,844) | (86,696) |
Acquisitions of real estate assets | (3,779) | (2,020) |
Proceeds from sales of real estate assets | 31,793 | 41,411 |
Purchase of marketable securities | (3,894) | (3,328) |
Proceeds from sale of marketable securities | 4,599 | 4,019 |
Net cash used in investing activities | (34,125) | (46,614) |
Financing activities: | | |
Repayment of secured debt obligations | 0 | (7,000) |
Repayment of borrowings under unsecured revolving credit facility | 0 | (7,500) |
Proceeds from borrowings under unsecured revolving credit facility | 0 | 646,000 |
Proceeds from unsecured notes | 349,360 | 0 |
Repayment of borrowings under unsecured term loans | (350,000) | 0 |
Deferred financing and debt extinguishment costs | (3,088) | (404) |
Partner distributions and repurchases of OP Units | (70,063) | (113,983) |
Net cash provided by (used in) financing activities | (73,791) | 517,113 |
Net change in cash, cash equivalents and restricted cash | 2,597 | 565,569 |
Cash, cash equivalents and restricted cash at beginning of period | 360,073 | 21,507 |
Cash, cash equivalents and restricted cash at end of period | 362,670 | 587,076 |
Reconciliation to consolidated balance sheets: | | |
Cash and cash equivalents | 361,388 | 584,815 |
Cash, cash equivalents and restricted cash at end of period | 362,670 | 587,076 |
Supplemental disclosure of cash flow information: | | |
Cash paid for interest, net of amount capitalized of $931 and $1,063 | $ 54,388 | $ 47,023 |